rs200088200
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_033109.5(PNPT1):āc.1361C>Gā(p.Ala454Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000515 in 1,613,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPT1 | NM_033109.5 | c.1361C>G | p.Ala454Gly | missense_variant | 17/28 | ENST00000447944.7 | NP_149100.2 | |
PNPT1 | XM_005264629.3 | c.1121C>G | p.Ala374Gly | missense_variant | 17/28 | XP_005264686.1 | ||
PNPT1 | XM_017005172.2 | c.1121C>G | p.Ala374Gly | missense_variant | 16/27 | XP_016860661.1 | ||
PNPT1 | XM_047446161.1 | c.1361C>G | p.Ala454Gly | missense_variant | 17/20 | XP_047302117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPT1 | ENST00000447944.7 | c.1361C>G | p.Ala454Gly | missense_variant | 17/28 | 1 | NM_033109.5 | ENSP00000400646.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250714Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135612
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1460944Hom.: 0 Cov.: 37 AF XY: 0.0000523 AC XY: 38AN XY: 726814
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74288
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 12, 2020 | This variant is associated with the following publications: (PMID: 31752325, 23084291, 27759031) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 17, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 454 of the PNPT1 protein (p.Ala454Gly). This variant is present in population databases (rs200088200, gnomAD 0.003%). This missense change has been observed in individual(s) with combined oxidative phosphorylation deficiency (PMID: 31752325). ClinVar contains an entry for this variant (Variation ID: 548987). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PNPT1 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Combined oxidative phosphorylation defect type 13 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The heterozygous p.Ala454Gly variant in PNPT1 has been identified in the compound heterozygous state by our project in one individual with Combined Oxidative Phosphorylation Deficiency (COPD). The p.Ala454Gly variant has not been reported in the literature, but it has been identified to have a MAF of 0.02% (1/6437) by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs200088200). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. The Alanine (Ala) at position 454 is highly conserved in mammals and evolutionary distant species, raising the possibility/supporting that a change at this position may not be tolerated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. Functional evidence (PNPase Western Blot, spectrophotometric enzyme assays, Dipstick assays, OXPHOS western blot) supports a pathogenic role for this variant and is consistent with other pathogenic variants (7 publications to date). The spectrophotometric enzyme assays conducted on fibroblasts were normal, which has been observed in other PNPT1- related cases including the one published in EJHG (Alodaib, A., et al. 2016) and others (Vedrenne, V., et al. 2012, Sato, R., et al. 2017). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at